Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

New genes found linked to balding, may help develop future treatments.

Genomic approach finds new possible treatments for hair loss.

Father's finasteride use may affect son's fertility and testicular function.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

The protein STAT3 slows down cell growth by blocking the FST gene, which affects hair development in sheep.

Melatonin helps hair grow by activating the RORα receptor in goats.

The research concluded that selection significantly shaped the genetic variation of the X chromosome, with certain regions affected by past selective events.

Genetic marker rs12558842 strongly linked to male hair loss.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Male pattern baldness does not cause an increased risk of prostate cancer.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Genetic factors could lead to personalized treatments for hair loss.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

New models predict male pattern baldness better than old ones but still need improvement.